Brief: Synektik, Nucleo Sign Agreement For Glunektik Production License
Sept 12 (Reuters) - Synektik SA SNTP.WA: SIGNS AGREEMENT FOR GLUNEKTIK PRODUCTION LICENSE AGREEMENT FOR MANUFACTURING AND DISTRIBUTION OF RADIOPHARMACEUTICAL NUCLEO TO PRODUCE AND DISTRIBUTE GLUNEKTIK IN LATVIA AND ESTONIA TO RECEIVE ONE-TIME AND QUARTERLY LICENSING FEES AGREEMENT SIGNED FOR 3 YEARS WITH EXTENSION OPTION GLUNEKTIK USED FOR PET IMAGING IN ONCOLOGY AND CARDIOLOGY Source text: ID:nEM8tx1bRa Further company coverage: SNTP.WA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Synektik SA
See all newsBrief: Synektik Signs Contracts For Ct And Mri Systems Worth 22.5 Mln Zlotys Net
Brief: Synektik Signs Max 10.5 Mln Zloty Deal For Supply Of Da Vinci System Consumables With Krakow University Hospital
Brief: Synektik Signs Deal With Private Company In Slovakia For Sale And Installation Of Vinci 5 System
Brief: Synektik Signs 16.1 Mln Zloty Deal To Deliver Da Vinci Robotic Surgery System To Hospital In Krakow
Brief: Synektik Q4 FY2025 Medical Equipment Orders At About 70 Mln Zlotys